GLUE
Price
$19.53
Change
-$1.40 (-6.69%)
Updated
Feb 4 closing price
Capitalization
1.49B
35 days until earnings call
Intraday BUY SELL Signals
STRO
Price
$14.89
Change
+$0.06 (+0.40%)
Updated
Feb 4 closing price
Capitalization
126.85M
35 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GLUE vs STRO

Header iconGLUE vs STRO Comparison
Open Charts GLUE vs STROBanner chart's image
Monte Rosa Therapeutics
Price$19.53
Change-$1.40 (-6.69%)
Volume$1.12M
Capitalization1.49B
Sutro Biopharma
Price$14.89
Change+$0.06 (+0.40%)
Volume$101.07K
Capitalization126.85M
GLUE vs STRO Comparison Chart in %
GLUE
Daily Signal:
Gain/Loss:
STRO
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GLUE vs. STRO commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLUE is a Hold and STRO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (GLUE: $19.53 vs. STRO: $14.89)
Brand notoriety: GLUE and STRO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLUE: 62% vs. STRO: 80%
Market capitalization -- GLUE: $1.49B vs. STRO: $126.85M
GLUE [@Biotechnology] is valued at $1.49B. STRO’s [@Biotechnology] market capitalization is $126.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLUE’s FA Score shows that 1 FA rating(s) are green whileSTRO’s FA Score has 1 green FA rating(s).

  • GLUE’s FA Score: 1 green, 4 red.
  • STRO’s FA Score: 1 green, 4 red.
According to our system of comparison, both GLUE and STRO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLUE’s TA Score shows that 5 TA indicator(s) are bullish while STRO’s TA Score has 2 bullish TA indicator(s).

  • GLUE’s TA Score: 5 bullish, 4 bearish.
  • STRO’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, GLUE is a better buy in the short-term than STRO.

Price Growth

GLUE (@Biotechnology) experienced а -7.57% price change this week, while STRO (@Biotechnology) price change was -4.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.41%. For the same industry, the average monthly price growth was +1.41%, and the average quarterly price growth was +32.47%.

Reported Earning Dates

GLUE is expected to report earnings on Mar 12, 2026.

STRO is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (-2.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLUE($1.49B) has a higher market cap than STRO($127M). STRO YTD gains are higher at: 28.695 vs. GLUE (24.554). GLUE has higher annual earnings (EBITDA): 16.8M vs. STRO (-166.43M). GLUE has more cash in the bank: 391M vs. STRO (168M). STRO has less debt than GLUE: STRO (17.7M) vs GLUE (40.2M). GLUE has higher revenues than STRO: GLUE (182M) vs STRO (106M).
GLUESTROGLUE / STRO
Capitalization1.49B127M1,174%
EBITDA16.8M-166.43M-10%
Gain YTD24.55428.69586%
P/E Ratio61.09N/A-
Revenue182M106M172%
Total Cash391M168M233%
Total Debt40.2M17.7M227%
FUNDAMENTALS RATINGS
STRO: Fundamental Ratings
STRO
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLUESTRO
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
Bearish Trend 11 days ago
89%
Bearish Trend 8 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 7 days ago
89%
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
GLUE
Daily Signal:
Gain/Loss:
STRO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLASF9.200.24
+2.68%
Glass House Brands Inc.
NPSCY4.370.08
+1.86%
Nippon Steel Corporation
CDPYF28.210.31
+1.09%
Canadian Apartment Properties Real Estate Investment Trust
CBWA16.94N/A
N/A
Commencement Bancorp Inc
GHST0.03N/A
N/A
GHST World Inc.

GLUE and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLUE has been closely correlated with STRO. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if GLUE jumps, then STRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLUE
1D Price
Change %
GLUE100%
-6.69%
STRO - GLUE
68%
Closely correlated
+0.40%
ACET - GLUE
68%
Closely correlated
-3.51%
GLSI - GLUE
67%
Closely correlated
-3.62%
ERAS - GLUE
67%
Closely correlated
+6.19%
TERN - GLUE
66%
Closely correlated
-6.39%
More